Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 4Carcinoma, Hepatocellular 2Small Cell Lung Carcinoma 1Motor Activity 1Lung Neoplasms 1Glioblastoma 1Fibrosis 1Epilepsy 1Cognitive Dysfunction 1Breast Neoplasms 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Exercise 34Nutritional Status 5Control Groups 4Resistance Training 3High-Intensity Interval Training 3lime 2Vitamin D 2Standard of Care 2Preoperative Exercise 2Dosage Forms 2Diet 2tislelizumab 1pembrolizumab 1oncomodulin 1diacetamate 1blueberry extract 1beta-Glucans 1Whey Proteins 1Wearable Electronic Devices 1Walking 1Transcranial Direct Current Stimulation 1Tea 1Tablets 1TEMPO 1Spermine Synthase 1Roflumilast 1Rehabilitation 1Probiotics 1Physical Therapy Modalities 1Physical Examination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Motor Activity × Memantine × Clear all
NCT06727773 2026-05-06

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
90 enrolled
Breast

Breast Neoplasms, Motor Activity, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡